Frontage Holdings Corporation (1521.HK)

1.260 -0.020 (-1.56%) At close: 04:08PM HKT

Frontage Holdings Corporation

700 Pennsylvania Drive
Exton, PA 19341
United States
610-232-0100
https://www.frontagelab.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 1,759

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Song Li Ph.D.	Founder & Chairman	6.03M	N/A	1957
Dr. Abdul Ezaz Mutlib Ph.D.	Chief Executive Officer	6.48M	N/A	1961
Mr. Jun Gao	CFO & President of Asia Pacific	70.31k	N/A	1976
Mr. Richard Fischetti J.D.	VP & General Counsel of Frontage Labs	N/A	N/A	1983
Dr. Zhongping Lin Ph.D.	President of Frontage Labs	N/A	N/A	1964
Dr. Tianyi Zhang	Senior VP of the Group & GM of Frontage Shanghai	N/A	N/A	1969
Mr. Sudendra Rao Ph.D.	Senior Vice President of Human Resources - North America	N/A	N/A	N/A
Dr. Wentao Zhang Ph.D.	Executive Vice President of Global Drug Discovery Services	N/A	N/A	N/A
Dr. John Kapeghian Ph.D.	Senior Vice President of Global Safety & Toxicology	N/A	N/A	N/A
Dr. Vishal Gupta Ph.D.	Executive Vice President of Global CMC & CDMO Services	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services. The company also provides early stage clinical/bioequivalence services; absolute bioavailability and human radiolabel studies; and chemistry services, including performing custom synthesis. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.

Corporate governance

Frontage Holdings Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.